Microspheres for drug delivery

For medical device manufacturers and hospital networks, microspheres for drug delivery is a sensitive decision on three dimensions: regulatory compliance (ANVISA, FDA, CE MDR — each with its own process and years of qualification), clinical performance (patients depend on the product working as specified), and civil liability in case of failure.

Current drivers. Population aging expands demand for chronic devices — continuous monitoring, orthopedics, prolonged ventilation. Hospital digitalization creates new wearable products with specific requirements. Global regulatory hardening (European MDR replacing MDD, updated FDA QSR) forces supplier requalification and opens windows for those with structured compliance. ISO 10993 biocompatibility and supply chain traceability became basic requirements, not differentiators.